Two Sigma Investments, LP Curis Inc Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.99 $24,460 - $42,484	-42,914 Reduced 36.84%	73,563 $61,000
Q1 2023 May 15, 2023	BUY	$0.51 - $0.78 $37,815 - $57,836	74,149 Added 175.18%	116,477 $69,000
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $39,636 - $1.45 Million	-84,332 Reduced 66.58%	42,328 $23,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $823,161 - $16.7 Million	-1,112,380 Reduced 89.78%	126,660 $89,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $181,309 - $620,539	255,366 Added 25.96%	1,239,040 $1.22 Million
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $1.71 Million - $3.8 Million	740,999 Added 305.35%	983,674 $2.34 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $760,909 - $1.38 Million	170,991 Added 238.53%	242,675 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $3.32 Million - $4.24 Million	-478,720 Reduced 86.98%	71,684 $561,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $4.1 Million - $8.96 Million	550,404 New	550,404 $4.44 Million
Q4 2018 Feb 14, 2019	SELL	$0.62 - $2.25 $15,950 - $57,883	-25,726 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $13,889 - $19,526	-10,065 Reduced 28.12%	25,726 $46,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $61,918 - $119,899	35,791 New	35,791 $62,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.